Publications

Journal Article
Research Support, Non-U.S. Gov't
Ppublish 39 citations
Electronic publication date
February 2, 2016

View on Pubmed.gov 25824771 | View on doi.org 10.7314/apjcp.2...

MiR-454 prompts cell proliferation of human colorectal cancer cells by repressing CYLD expression.

Search for publications in this journal Asian Pac J Cancer Prev - 16(6):2397-402

  • Hong-Liang Liang

    Search for this expert
    1
  • Ai-Ping Hu

    Search for this expert
  • Sen-Lin Li

    Search for this expert
  • Jia-Ping Xie
  • Qing-Zhu Ma

    Search for this expert
  • Ji-Yong Liu

    Search for this expert

Abstract

Previous studies have shown that miR-454 plays an important role in a variety of biological processes in various human cancer cells. However, the underlying mechanisms of this microRNA in colorectal cancer (CRC) cells remain largely unknown. In the present study, we investigated the miR-454 role in CRC cell proliferation. We found that miR-454 expression is markedly upregulated in CRC tissues and CRC cells compared with the matched tumor adjacent tissues and the FHC normal colonic cell line. Ectopic expression of miR-454 promoted the proliferation and anchorage-independent growth of CRC cells, whereas inhibition of miR-454 reduced this effect. Bioinformatics analysis further revealed cylindromatosis (CYLD), a putative tumor suppressor as a potential target of miR-454. Data from luciferase reporter assays showed that miR-454 directly binds to the 3'-untranslated region (3'-UTR) of CYLD mRNA and repressed expression at both transcriptional and translational levels. In functional assays, CYLD-silenced in miR-454-in-transfected SW480 cells have positive effect to promote cell proliferation, suggesting that direct CYLD downregulation is required for miR-454-induced CRC cell proliferation. In sum, our data provide compelling evidence that miR-454 functions as an onco-miRNA, playing a crucial role in the promoting cell proliferation in CRC, and its oncogenic effect is mediated chiefly through direct suppression of CYLD expression.

References

No references provided.

Cited by 39 citations (total)

Journal Article

MiR-185 acts as a tumor suppressor by targeting AKT1 in non-small cell lung cancer cells.

Electronic publication date September 27, 2016

Search for publications in this journal Int J Clin Exp Pathol

Shuai Li [...] Jufeng Wang et al.

Increasing evidence has shown that microRNAs play critical roles in the initiation and progression of non-small cell lung cancer (NSCLC)....

Comparative Study Journal Article Research Support, Non-U.S. Gov't

Comparison of the miRNA profiles in HPV-positive and HPV-negative tonsillar tumors and a model system of human keratinocyte clones.

Electronic publication date October 17, 2017

Search for publications in this journal BMC Cancer

Zuzana Vojtechova [...] Ruth Tachezy et al.

BACKGROUND

Better insights into the molecular changes involved in virus-associated and -independent head and neck cancer may advance our knowledge of...

Conflict of interest statement

No conflict of interest statement provided.

MeSH

Specialties

Substances